[TRIAL TREATMENT OF VARIOUS "PROTEUS" INFECTIONS WITH 2,4-DIAMINO-5-(3,4,5-TRIMETHOXYBENZYL)  PYRIMIDINE, OR (TRIM'ETHOPRIME)].
D004357:Drug Synergism; D004358:Drug Therapy; D005492:Folic Acid; D006402:Hematologic Diseases; D006801:Humans; D008660:Metabolism; D009369:Neoplasms; D011109:Polymethacrylic Acids; D011511:Proteus; D011512:Proteus Infections; D011743:Pyrimidines; D012141:Respiratory Tract Infections; D018805:Sepsis; D012871:Skin Diseases; D013449:Sulfonamides; D014552:Urinary Tract Infections
D011109:Polymethacrylic Acids; D011743:Pyrimidines; D013449:Sulfonamides; C091347:vinyl ethyl methacrylate; D005492:Folic Acid; C030986:pyrimidine
DRUG SYNERGISM; DRUG THERAPY; FOLIC ACID; HEMATOLOGIC DISEASES; METABOLISM; NEOPLASMS; PROTEUS INFECTIONS; PYRIMIDINES; RESPIRATORY TRACT INFECTIONS; SEPTICEMIA; SKIN DISEASES; SULFONAMIDES; URINARY TRACT INFECTIONS
ESSAI DE TRAITEMENT DE DIVERSES IN FECTIONS 'A "PROTEUS" PAR LE 2,4-DIAMINO-5-(3,4,5-TRIM'ETHOXYBENZYL) PYRIMIDINE, OU (TRIM'ETHOPRIME)